DCAT Value Chain Insights

Market Watch: Dosage-Form Development and Manufacturing

Formulation and drug-delivery technologies play an important role in new product development, both in formulations with new active pharmaceutical ingredients (APIs) and in new routes of...

Re-configuring Global Pharma Supply Chains

In the wake of the COVID-19 pandemic and concerns over pharmaceutical supply-chain vulnerabilities, the policy debate to repatriate and increase domestic drug manufacturing in the US is receiving...

SPONSORED CONTENT

A Cambrex Webinar - Understanding the Importance of Crystallization Processes to Avoid Unnecessary Cost, Risk and Development Delays

Information
June 8, 2020
Sponsored by Cambrex

Dr. Craig Callahan, Project Scientist, Cambrex Edinburgh, discusses the importance of understanding crystallization processes to avoid unnecessary cost, risk and development delays.

Read More
Overcoming Challenges to Deliver Fixed Dose Combination (FDC) Drug Products

Information
June 2, 2020
Sponsored by Cambrex

With Cambrex’s experience in combining two or more active pharmaceutical ingredients (APIs) into Fixed Dose Combination drugs (FDCs), we are the CDMO that’s expertly positioned to partner with you...

Read More
Q&A with Stephan Haitz, President, CDMO Sales & Marketing at Cambrex

Information
March 9, 2020
Sponsored by Cambrex

Stephan Haitz, President, CDMO Sales & Marketing discusses small molecule trends and how the CDMO industry is constantly evolving to meet the demands and needs of the growing clinical pipeline.

Read More